Trial Profile
Randomized, Double-blind, Parallel, Entecavir-controlled, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Morphothiadine Mesilate Capsules/Ritonavir Tablets in Patients with Chronic Hepatitis B
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2016
Price :
$35
*
At a glance
- Drugs Morphothiadine (Primary) ; Ritonavir
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 26 Aug 2016 New trial record